imatinib mesylate has been researched along with Di Guglielmo Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (76.47) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Granot, G; Ovcharenko, A; Park, J; Raanani, P; Rokah, OH; Shpilberg, O | 1 |
| Guo, Q; Hui, H; Li, H; Lu, N; Wang, Q; Wang, X; Yang, H; You, Q; Zhao, K; Zhou, Y; Zhu, Y | 1 |
| Cools, J; De Keersmaecker, K; Hantschel, O; Superti-Furga, G; Versele, M | 1 |
| Bakhanashvili, M; Granot, G; Lahav, J; Lahav, M; Mor-Tzuntz, R; Raanani, P; Rabizadeh, E; Shpilberg, O; Uziel, O; Zimra, Y | 1 |
| Kalle, AM; Pallu, R; Sachchidanand, S | 1 |
| Boehrer, S; Brieger, A; Chow, KU; Hoelzer, D; Kukoc-Zivojnov, N; Mitrou, PS; Nowak, D; Ruthardt, M; Schaaf, S; Weidmann, E | 1 |
| Arock, M; Bonnemye, P; Hamouda, NB; Kuen, RL; Leriche, L; Merle-Beral, H; N'Guyen Khac, F; Piffaut, MC; Ribadeau Dumas, A; Tricottet, V | 1 |
| Bonnet, ML; Bourhis, J; Deutsch, E; Frascogna, V; Khanfir, K; Maggiorella, L; Turhan, AG; Wen, B | 1 |
| Cao, YX; Feng, Q; Liu, XP; Shang, ZC; Sun, BZ; Wang, W; Yao, LB | 1 |
| Denis, N; Dubreuil, P; Kosmider, O; Lacout, C; Moreau-Gachelin, F; Vainchenker, W | 1 |
| Hassel, BA; Nakanishi, T; Ross, DD; Shiozawa, K | 1 |
| Fotiadis, NA; Kirk, MJ; Majumdar, SK | 1 |
| Calabrese, G; Catinella, V; Fioritoni, G; Franchi, PG; Iacone, A; Mennucci, A; Palka, G; Pompetti, F; Russo, R; Sau, A; Spadano, A | 1 |
| Kida, A; Koyama, T; Kurosu, T; Miura, O; Tsuji, K; Yamamoto, M | 1 |
| Anderson, KC; Barilà, D; Chauhan, D; DePinho, RA; Hideshima, T; Podar, K; Raab, MS; Raje, N; Sattler, M; Tai, YT; Tonon, G; Yasui, H; Zhang, J | 1 |
| Hamada, A; Hirayama, C; Kawaguchi, T; Kuniyasu, A; Nakashima, R; Nakayama, H; Nanbu, T; Saito, H; Watanabe, H | 1 |
| Craig, J; Cunningham, J; Gelly, K; Pippard, MJ; Sales, M; Tauro, S; Walker, K | 1 |
17 other study(ies) available for imatinib mesylate and Di Guglielmo Disease
| Article | Year |
|---|---|
Enhanced adhesion/migration and induction of Pyk2 expression in K562 cells following imatinib exposure.
Topics: Antineoplastic Agents; Benzamides; Cell Adhesion; Cell Movement; Drug Evaluation, Preclinical; Focal Adhesion Kinase 2; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Erythroblastic, Acute; Neoplasm Invasiveness; Piperazines; Pyrimidines; RNA, Small Interfering; Up-Regulation | 2013 |
Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Cycle Checkpoints; Cell Differentiation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Erythroid Cells; Extracellular Signal-Regulated MAP Kinases; Female; Flavanones; GATA1 Transcription Factor; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Kinase Kinases; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Piperazines; Protein Kinase Inhibitors; Pyrimidines; RNA Interference; Signal Transduction; Time Factors; Transcription Factors; Transfection; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
Topics: Benzamides; Dasatinib; Enzyme Activation; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; In Vitro Techniques; K562 Cells; Leukemia, Erythroblastic, Acute; Oncogene Proteins, Fusion; Phosphorylation; Piperazines; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Substrate Specificity; Thiazoles | 2008 |
Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib.
Topics: Antineoplastic Agents; Base Sequence; Benzamides; Blotting, Western; Cell Cycle; Cell Division; DNA Primers; Genes, abl; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Erythroblastic, Acute; Phosphatidylinositol 3-Kinases; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Telomerase | 2010 |
Bcr-Abl-independent mechanism of resistance to imatinib in K562 cells: Induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs).
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Benzamides; Cyclooxygenase 2; DNA Primers; Drug Resistance, Neoplasm; Enzyme Activation; Fusion Proteins, bcr-abl; Gene Knockdown Techniques; Histone Deacetylases; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Erythroblastic, Acute; Piperazines; Protein Kinase C; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering | 2010 |
In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Benzamides; Carrier Proteins; Caspase 10; Caspase 8; Caspase 9; Caspases; Cell Line, Tumor; Co-Repressor Proteins; Enzyme Precursors; fas Receptor; Gene Expression Regulation, Leukemic; Genes, bcl-2; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Leukemia, Erythroblastic, Acute; Membrane Glycoproteins; Molecular Chaperones; Neoplasm Proteins; Nuclear Proteins; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Necrosis Factor-alpha | 2004 |
Establishment and characterization of a new human erythroleukemic cell line, ERY-1.
Topics: Aged; Aged, 80 and over; Antigens, CD; Benzamides; Cell Line, Tumor; Chromosomes, Human, Pair 8; Female; Fusion Proteins, bcr-abl; Gene Duplication; Globins; Humans; Imatinib Mesylate; Immunophenotyping; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenotype; Piperazines; Pyrimidines; Receptors, Erythropoietin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Translocation, Genetic; Trisomy | 2004 |
Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; DNA-Activated Protein Kinase; DNA-Binding Proteins; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Mice; Mice, Nude; Neoplasm Recurrence, Local; Nuclear Proteins; Phosphorylation; Piperazines; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Tumor Cells, Cultured; Tyrphostins | 2004 |
Effects of STI571 and p27 gene clone on proliferation and apoptosis of K562 cells.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Benzamides; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p27; Genetic Therapy; Humans; Imatinib Mesylate; In Vitro Techniques; K562 Cells; Leukemia, Erythroblastic, Acute; Molecular Sequence Data; Piperazines; Pyrimidines; Transfection; Tumor Suppressor Proteins | 2005 |
Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice.
Topics: Animals; Benzamides; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Mice; Mice, Transgenic; Mutation; Piperazines; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrimidines; Time Factors; Trans-Activators | 2005 |
Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Indoles; K562 Cells; Leukemia, Erythroblastic, Acute; Mitoxantrone; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; RNA, Messenger; Signal Transduction; Transduction, Genetic | 2006 |
An in vitro study of the cytogenetic and cytotoxic effects of imatinib mesylate, STI571 on murine erythroleukemia GM-86 cells.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Nucleus; Cell Proliferation; Chromosome Aberrations; Humans; Imatinib Mesylate; In Vitro Techniques; Karyotyping; Leukemia, Erythroblastic, Acute; Mice; Mitotic Index; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Tumor Cells, Cultured | 2006 |
Long-term remission in BCR/ABL-positive AML-M6 patient treated with Imatinib Mesylate.
Topics: Antineoplastic Agents; Benzamides; Cytogenetic Analysis; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Remission Induction | 2007 |
Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta.
Topics: Acetophenones; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Benzopyrans; Drug Synergism; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Erythroblastic, Acute; Mice; Mitochondria; Piperazines; Protein Kinase C-delta; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Uncoupling Agents; Up-Regulation | 2007 |
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma.
Topics: Adamantane; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Caspase Inhibitors; Caspases; Cell Growth Processes; Dexamethasone; Humans; Hydroquinones; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Melphalan; Multiple Myeloma; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-jun; Pyrazines; Pyrimidines; Transfection; Up-Regulation | 2007 |
Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Cell Survival; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Imatinib Mesylate; Indoles; K562 Cells; Leukemia, Erythroblastic, Acute; Neoplasm Proteins; Organic Cation Transporter 1; Piperazines; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pyrimidines; Up-Regulation | 2008 |
Sequential tyrosine kinase inhibitor therapy: sustained disease remission in Philadelphia-positive erythroleukaemia.
Topics: Benzamides; Dasatinib; Female; Humans; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles | 2008 |